机构

• 上海药物研究所 [7]

采集方式

• OAI收割 [7]

内容类型

• 期刊论文 [7]

发表日期

• 2023 [1]
• 2022 [1]
• 2021 [1]
• 2019 [1]
• 2014 [1]
• 2013 [1]
• 更多

学科主题

筛选

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Discovery, structural optimization, and anti-tumor bioactivity evaluations of betulinic acid derivatives as a new type of ROR & gamma; antagonists 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 257, 页码: 15 作者:  Mei, Lianghe;  Xu, Lansong;  Wu, Sanan;  Wang, Yafang;  Xu, Chao   |  收藏  |  浏览/下载：39/0  |  提交时间：2023/10/17 Betulinic acid  ROR & gamma  Target identification  Rationale structure optimization  Anti-tumor effects  antagonists   Dual-acting antitumor agents targeting the A2A adenosine receptor and histone deacetylases: Design and synthesis of 4-(furan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine derivatives 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 236, 页码: 114326 作者:  Zhang, Jinfeng;  Luo, Ziwei;  Duan, Wenwen;  Yang, Kexin;  Ling, Lijun   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/03/21 Bifunctional  Structure-based  Cancer  Immunotherapy   Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A(2A) Receptor and Histone Deacetylase as Novel Tumor Immunotherapeutic Agents 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 22, 页码: 16573-16597 作者:  Yan, Wenzhong;  Ling, Lijun;  Wu, Yiran;  Yang, Kexin;  Liu, Ruiquan   |  收藏  |  浏览/下载：16/0  |  提交时间：2022/06/15 Pharmacologic characterization of fluzoparib, a novel poly(ADP-ribose) polymerase inhibitor undergoing clinical trials 期刊论文  OAI收割 CANCER SCIENCE, 2019, 卷号: 110, 期号: 3, 页码: 1064-1075 作者:  Wang, Lei;  Yang, Changyong;  Xie, Chengying;  Jiang, Jiahua;  Gao, Mingzhao   |  收藏  |  浏览/下载：21/0  |  提交时间：2020/07/01 antitumor activity  fluzoparib  pharmacokinetics  poly(ADP-ribose) polymerase  toxicity   Synthesis, anticancer activity and toxicity of a water-soluble 4S,5S-derivative of heptaplatin, cis-{Pt(II)[(4S,5S)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane].(3-hydroxyl-cyclobutane-1,1-dicarboxylate)} 期刊论文  OAI收割 JOURNAL OF INORGANIC BIOCHEMISTRY, 2014, 卷号: 140, 页码: 126-130 作者:  Liu, Weiping;  Jiang, Jing;  Xie, Chengying;  Hou, Shuqian;  Quan, Haitian   |  收藏  |  浏览/下载：15/0  |  提交时间：2019/01/08 Platinum complexes  Anticancer activity  Toxicity  Heptaplatin  Derivative   cis-[Pt-II(1R,2R-DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)], a Water-Soluble, Oxalate-Free and Stable Analogue of Oxaliplatin: Synthesis, Characterization, and Biological Evaluations 期刊论文  OAI收割 CHEMMEDCHEM, 2013, 卷号: 8, 期号: 9, 页码: 1465-1467 作者:  Liu, Weiping;  Ye, Qingsong;  Jiang, Jing;  Lou, Liguang;  Xu, Yongping   |  收藏  |  浏览/下载：20/0  |  提交时间：2019/01/08 antitumor agents  biological activity  oxaliplatin  platinum  synthesis   Synthesis and cytotoxicity of diam(m)ineplatinum(II) complexes with 2,2-bis(hydroxymethyl)malonate as the leaving group 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 卷号: 22, 期号: 6, 页码: 2239-2241 作者:  Xing, Yingjuan;  Lou, Liguang;  Chen, Xizhu;  Ye, Qingsong;  Xu, Yongping   |  收藏  |  浏览/下载：9/0  |  提交时间：2019/01/08 Platinum  2,2-bis(Hydroxymethyl)malonate  Synthesis  Anticancer activity